Конгресс
nidek
www.worldglaucoma.org
appstore
ВК
santen
профессор
Первая пятница декабря
Beaver
конгресс 2018
icgs2018
Основные мероприятия ассоциации офтальмологов
Торика
oftalmolog_club
Конгресс 2014
Шахматы
varthamana2
YouTube
medlab
eye5
Ассоциации
АйНьюс.РФ
facebook
Mobile
bannerparasol
Флаги
askin_heid
glaucoma_net_ru
Главная / Новости / Twenty-year outcomes in patients with newly diagnosed glaucoma: mortality and visual function
16 дней назад
05 апреля 2018

Twenty-year outcomes in patients with newly diagnosed glaucoma: mortality and visual function

METHODS: Twenty years following the diagnosis of COAG in 68 of 436 (16%) patients seen in a glaucoma case-finding clinic, visual and mortality outcomes were audited from medical records. Causes of death were obtained from general practitioner records and death certificates. Probability of death was calculated using a Kaplan-Meier survival curve. The visual field of each eye of survivors was graded using a nine-stage severity scale. Visual outcome was analysed at the 20-year follow-up visit.

RESULTS: From 68, 14 (21%) were lost to follow-up. In the remaining 54, 20 (37%) were alive 20 years after diagnosis. Of 63% who died, mean age of death was 84 years, most commonly due to vascular disease. Mean age at presentation of those who died was 73.7 years versus 63.2 years for survivors (P=0.001). The median time to death was 16 years. On visual field analysis, nearly half (48.9%) of eyes did not deteriorate, but 28.3% eyes deteriorated by more than two stages. Those who died had worse final visual acuity than survivors (P<0.001). Three who died were registered severely visually impaired mainly from macular disease, but no survivors were registered (P<0.001).

CONCLUSION: In this cohort, approximately two-thirds of patients with glaucoma died within 20 years of diagnosis. In most older patients with glaucoma, the overall goal of preventing visual handicap and blindness is achievable 20 years after diagnosis.

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Br J Ophthalmol. 2018 Mar 3. pii: bjophthalmol-2017-311595. doi: 10.1136/bjophthalmol-2017-311595.

http://www.ncbi.nlm.nih.gov/pubmed/29502068 


Journal manager: Andreas Boehm

Голосование
Что "заставляет" Вас заниматься научными исследованиями?